Phosphatidylinositol 4,5-bisphosphate optical uncaging potentiates exocytosis

  1. Alexander M Walter  Is a corresponding author
  2. Rainer Müller
  3. Bassam Tawfik
  4. Keimpe DB Wierda
  5. Paulo S Pinheiro
  6. André Nadler
  7. Anthony W McCarthy
  8. Iwona Ziomkiewicz
  9. Martin Kruse
  10. Gregor Reither
  11. Jens Rettig
  12. Martin Lehmann
  13. Volker Haucke
  14. Bertil Hille
  15. Carsten Schultz
  16. Jakob Balslev Sorensen  Is a corresponding author
  1. University of Copenhagen, Denmark
  2. European Molecular Biology Laboratory (EMBL), Germany
  3. Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Germany
  4. University of Washington School of Medicine, United States
  5. Saarland University, Germany

Abstract

Phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] is essential for exocytosis. Classical ways of manipulating PI(4,5)P2 levels are slower than metabolism, making it difficult to distinguish effects of PI(4,5)P2 from those of its metabolites. We developed a membrane-permeant, photoactivatable PI(4,5)P2, which is loaded into cells in an inactive form and activated by light, allowing sub-second increases in PI(4,5)P2 levels. By combining this compound with electrophysiological measurements in mouse adrenal chromaffin cells, we show that PI(4,5)P2 uncaging potentiates exocytosis and identify synaptotagmin-1 (the Ca2+ sensor for exocytosis) and Munc13-2 (a vesicle priming protein) as the relevant effector proteins. PI(4,5)P2 activation of exocytosis did not depend on the PI(4,5)P2-binding CAPS-proteins, suggesting that PI(4,5)P2 uncaging bypasses CAPS-function. Finally, PI(4,5)P2 uncaging triggered the rapid fusion of a subset of readily-releasable vesicles, revealing a rapid role of PI(4,5)P2 in fusion triggering. Thus, optical uncaging of signaling lipids can uncover their rapid effects on cellular processes and identify lipid effectors.

Article and author information

Author details

  1. Alexander M Walter

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    For correspondence
    awalter@fmp-berlin.de
    Competing interests
    No competing interests declared.
  2. Rainer Müller

    Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3464-494X
  3. Bassam Tawfik

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1193-8494
  4. Keimpe DB Wierda

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8784-9490
  5. Paulo S Pinheiro

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
  6. André Nadler

    Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Competing interests
    No competing interests declared.
  7. Anthony W McCarthy

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
    Competing interests
    No competing interests declared.
  8. Iwona Ziomkiewicz

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    Iwona Ziomkiewicz, Performed experiments as an employee of University of Copenhagen and is now an employee of AstraZeneca; IZ has no financial investments in AstraZeneca.
  9. Martin Kruse

    Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, United States
    Competing interests
    No competing interests declared.
  10. Gregor Reither

    Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Competing interests
    No competing interests declared.
  11. Jens Rettig

    Center for Integrative Physiology and Molecular Medicine, Saarland University, Homburg, Germany
    Competing interests
    No competing interests declared.
  12. Martin Lehmann

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
    Competing interests
    No competing interests declared.
  13. Volker Haucke

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
    Competing interests
    No competing interests declared.
  14. Bertil Hille

    Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, United States
    Competing interests
    No competing interests declared.
  15. Carsten Schultz

    Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Competing interests
    No competing interests declared.
  16. Jakob Balslev Sorensen

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    For correspondence
    jakobbs@sund.ku.dk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5465-3769

Funding

European Union 7th Framework programme (HEALTH-F2-2009-242167)

  • Jakob Balslev Sorensen

The independent Research Fond Denmark

  • Jakob Balslev Sorensen

The Novo Nordisk Foundation

  • Jakob Balslev Sorensen

The Lundbeck Foundation

  • Paulo S Pinheiro
  • Jakob Balslev Sorensen

European Molecular Biology Laboratory

  • Carsten Schultz

Deutsche Forschungsgemeinschaft (Transregio83)

  • Alexander M Walter
  • Carsten Schultz

Deutsche Forschungsgemeinschaft (Emmy Noether Programme)

  • Alexander M Walter

National Institutes of Health (R37NS008174)

  • Bertil Hille

Alexander von Humboldt-Stiftung

  • Martin Kruse

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Permission to keep and breed knockout mice for this study was obtained from The Danish Animal Experiments Inspectorate (2006/562−43, 2012−15−2935−00001). The animals were maintained in an AAALAC-accredited stable in accordance with institutional guidelines as overseen by the Institutional Animal Care and Use Committee (IACUC).

Copyright

© 2017, Walter et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,802
    views
  • 845
    downloads
  • 45
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alexander M Walter
  2. Rainer Müller
  3. Bassam Tawfik
  4. Keimpe DB Wierda
  5. Paulo S Pinheiro
  6. André Nadler
  7. Anthony W McCarthy
  8. Iwona Ziomkiewicz
  9. Martin Kruse
  10. Gregor Reither
  11. Jens Rettig
  12. Martin Lehmann
  13. Volker Haucke
  14. Bertil Hille
  15. Carsten Schultz
  16. Jakob Balslev Sorensen
(2017)
Phosphatidylinositol 4,5-bisphosphate optical uncaging potentiates exocytosis
eLife 6:e30203.
https://doi.org/10.7554/eLife.30203

Share this article

https://doi.org/10.7554/eLife.30203

Further reading

    1. Cell Biology
    2. Computational and Systems Biology
    Sarah De Beuckeleer, Tim Van De Looverbosch ... Winnok H De Vos
    Research Article

    Induced pluripotent stem cell (iPSC) technology is revolutionizing cell biology. However, the variability between individual iPSC lines and the lack of efficient technology to comprehensively characterize iPSC-derived cell types hinder its adoption in routine preclinical screening settings. To facilitate the validation of iPSC-derived cell culture composition, we have implemented an imaging assay based on cell painting and convolutional neural networks to recognize cell types in dense and mixed cultures with high fidelity. We have benchmarked our approach using pure and mixed cultures of neuroblastoma and astrocytoma cell lines and attained a classification accuracy above 96%. Through iterative data erosion, we found that inputs containing the nuclear region of interest and its close environment, allow achieving equally high classification accuracy as inputs containing the whole cell for semi-confluent cultures and preserved prediction accuracy even in very dense cultures. We then applied this regionally restricted cell profiling approach to evaluate the differentiation status of iPSC-derived neural cultures, by determining the ratio of postmitotic neurons and neural progenitors. We found that the cell-based prediction significantly outperformed an approach in which the population-level time in culture was used as a classification criterion (96% vs 86%, respectively). In mixed iPSC-derived neuronal cultures, microglia could be unequivocally discriminated from neurons, regardless of their reactivity state, and a tiered strategy allowed for further distinguishing activated from non-activated cell states, albeit with lower accuracy. Thus, morphological single-cell profiling provides a means to quantify cell composition in complex mixed neural cultures and holds promise for use in the quality control of iPSC-derived cell culture models.

    1. Cell Biology
    Joan Chang, Adam Pickard ... Karl E Kadler
    Research Article

    Collagen-I fibrillogenesis is crucial to health and development, where dysregulation is a hallmark of fibroproliferative diseases. Here, we show that collagen-I fibril assembly required a functional endocytic system that recycles collagen-I to assemble new fibrils. Endogenous collagen production was not required for fibrillogenesis if exogenous collagen was available, but the circadian-regulated vacuolar protein sorting (VPS) 33b and collagen-binding integrin α11 subunit were crucial to fibrillogenesis. Cells lacking VPS33B secrete soluble collagen-I protomers but were deficient in fibril formation, thus secretion and assembly are separately controlled. Overexpression of VPS33B led to loss of fibril rhythmicity and overabundance of fibrils, which was mediated through integrin α11β1. Endocytic recycling of collagen-I was enhanced in human fibroblasts isolated from idiopathic pulmonary fibrosis, where VPS33B and integrin α11 subunit were overexpressed at the fibrogenic front; this correlation between VPS33B, integrin α11 subunit, and abnormal collagen deposition was also observed in samples from patients with chronic skin wounds. In conclusion, our study showed that circadian-regulated endocytic recycling is central to homeostatic assembly of collagen fibrils and is disrupted in diseases.